Calquence
Calquence ingredients
| Active ingredient | Strength |
|---|---|
| Acalabrutinib | 100 mg/1 |
What Calquence is used for
The FDA lists the approved uses on the official label (below). In the EU, acalabrutinib is approved as Calquence for:
Calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL).Calquence in combination with venetoclax with or without obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL).Calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy.Calquence in combination with bendamustine and rituximab (BR) is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are not eligible for autologous stem cell transplant (ASCT).Calquence as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) not previously treated with a …
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Calquence
- Generic name
- Acalabrutinib
- Made by
- AstraZeneca Pharmaceuticals LP
- Forms
- Capsule, Gelatin Coated, Tablet, Film Coated
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA210259
- On the US market since
- 2017
Official information
- Calquence prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Acalabrutinib)
In India
- Acalabrutinib: 1 brand in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Calquence?
Calquence (Acalabrutinib) is a cancer medicine made by AstraZeneca Pharmaceuticals LP, approved by the US FDA.
What are the ingredients of Calquence?
Calquence contains Acalabrutinib (100 mg/1).
Is Calquence approved in Europe?
The same active substance is approved in the EU as Calquence.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA